Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
Core EBITDA Growth

    Back to All Ratios
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -11.54-12.5144.9880.9850.75

What is the latest Core EBITDA Growth ratio of INDOCO REMEDIES ?

The latest Core EBITDA Growth ratio of INDOCO REMEDIES is -11.54 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-11.54
Mar2023-12.51
Mar202244.98
Mar202180.98
Mar202050.75

How is Core EBITDA Growth of INDOCO REMEDIES Trending?

Years Core EBITDA Growth % Change
Mar2024 -11.54
Negative
Mar2023 -12.51
Negative
Mar2022 44.98
-44.46
Mar2021 80.98
59.57
Mar2020 50.75 -

Other Financial Ratios of INDOCO REMEDIES


Compare Core EBITDA Growth ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,983.1 Cr 1.3% 15.7% -0.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,267.0 Cr 0.7% 2.8% 7.9% Stock Analytics
DIVIS LABORATORIES ₹178,672.0 Cr -0.8% 3.7% 48.6% Stock Analytics
CIPLA ₹119,713.0 Cr -0.2% -0.1% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,195.0 Cr 3.4% 11.2% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,999.0 Cr 0.6% -5.2% -4.9% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

1.3%

15.7%

-0.5%

SENSEX

-0.9%

0.4%

1.4%


You may also like the below Video Courses